News & Media
The latest HCC research and news alongside curated videos and audio resources.
Latest HCC NewsUpdated every 4 hours
Medical XpressScientists uncover how cells surrounding primary liver tumors may help fuel cancer
UCLA researchers have identified a pathway in liver cells that may explain how statins could help prevent or slow the development of liver cancer associated with fatty liver disease.
Medical XpressProtein linked to cell death may also drive liver cancer
New research from the University of Oklahoma identifies a protein in liver cells that appears to help drive the development of liver cancer associated with obesity-related fatty liver disease. The finding, published in H
Medical XpressNovel immunotherapy leads to complete regression of chemotherapy-resistant liver cancer in 3-year-old
A new report in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children's Hospital and Seattle Children's describes a complete regression of hepatoblastoma, the most common pediat
News-Medical.netNew integrated framework advances precision surgery for liver cancer
Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally.
The StarHe was given six months to live. He spent it finding a home for his autistic son
SEOUL: Author Jeon Gyeong-cheol, widely known as the "Peter Pan Dad" for documenting his search for a home where his disabled son could live after his death, died Saturday. He was 64 and had been fighting late-stage live
Medical XpressMASH may require personalized treatment as distinct disease subtypes emerge
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, affecting an estimated 38% of adults worldwide. Its progressive form, MASH, is characterized by inflammation and
GizmodoAlcohol-Related Cancer Deaths in the US Have Doubled Since 1990, and Not Just Among Those With Liver Cancer
A new study found that alcohol-related cancer deaths in the U.S. have risen over the past three decades from an estimated 11,400 in 1990 to over 23,100 in 2023 annually.
ANI (Asian News International)ZoeNCure Therapeutics Secures License for Novel Antibody Platform from Styx Biotechnologies to Advance Next-Generation ADCs for Liver Cancer
New Delhi [India], September 3: ZoeNCure Therapeutics Pvt. Ltd., an oncology biotechnology company based in New Delhi, today announced a strategic licensing agreement with San Diego-based Styx Biotechnologies, Inc. Under
India TV NewsCan hepatitis B lead to liver cancer even before cirrhosis develops? Liver transplant surgeon explains
Hepatitis B can often be prevented, yet it remains a major cause of cirrhosis and liver cancer worldwide. Dr Vibha Varma explains why newborn vaccination, prevention of mother-to-child transmission, screening, early diag
The HinduHow transplant oncology is rewriting the story of liver cancer
Discover how transplant oncology is transforming liver cancer treatment by enabling successful transplants and improved patient outcomes.